Your browser doesn't support javascript.
loading
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning.
Lucido, J John; DeWees, Todd A; Leavitt, Todd R; Anand, Aman; Beltran, Chris J; Brooke, Mark D; Buroker, Justine R; Foote, Robert L; Foss, Olivia R; Gleason, Angela M; Hodge, Teresa L; Hughes, Cían O; Hunzeker, Ashley E; Laack, Nadia N; Lenz, Tamra K; Livne, Michelle; Morigami, Megumi; Moseley, Douglas J; Undahl, Lisa M; Patel, Yojan; Tryggestad, Erik J; Walker, Megan Z; Zverovitch, Alexei; Patel, Samir H.
Affiliation
  • Lucido JJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • DeWees TA; Department of Health Sciences Research, Mayo Clinic, Phoenix, AZ, United States.
  • Leavitt TR; Department of Health Sciences Research, Mayo Clinic, Phoenix, AZ, United States.
  • Anand A; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States.
  • Beltran CJ; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, United States.
  • Brooke MD; Google Health, Mountain View, CA, United States.
  • Buroker JR; Research Services, Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, United States.
  • Foote RL; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • Foss OR; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, United States.
  • Gleason AM; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, United States.
  • Hodge TL; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • Hughes CO; Google Health, Mountain View, CA, United States.
  • Hunzeker AE; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • Laack NN; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • Lenz TK; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • Livne M; Google Health, Mountain View, CA, United States.
  • Morigami M; Google Health, Mountain View, CA, United States.
  • Moseley DJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • Undahl LM; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • Patel Y; Google Health, Mountain View, CA, United States.
  • Tryggestad EJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
  • Walker MZ; Google Health, Mountain View, CA, United States.
  • Zverovitch A; Google Health, Mountain View, CA, United States.
  • Patel SH; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States.
Front Oncol ; 13: 1137803, 2023.
Article in En | MEDLINE | ID: mdl-37091160
Introduction: Organ-at-risk segmentation for head and neck cancer radiation therapy is a complex and time-consuming process (requiring up to 42 individual structure, and may delay start of treatment or even limit access to function-preserving care. Feasibility of using a deep learning (DL) based autosegmentation model to reduce contouring time without compromising contour accuracy is assessed through a blinded randomized trial of radiation oncologists (ROs) using retrospective, de-identified patient data. Methods: Two head and neck expert ROs used dedicated time to create gold standard (GS) contours on computed tomography (CT) images. 445 CTs were used to train a custom 3D U-Net DL model covering 42 organs-at-risk, with an additional 20 CTs were held out for the randomized trial. For each held-out patient dataset, one of the eight participant ROs was randomly allocated to review and revise the contours produced by the DL model, while another reviewed contours produced by a medical dosimetry assistant (MDA), both blinded to their origin. Time required for MDAs and ROs to contour was recorded, and the unrevised DL contours, as well as the RO-revised contours by the MDAs and DL model were compared to the GS for that patient. Results: Mean time for initial MDA contouring was 2.3 hours (range 1.6-3.8 hours) and RO-revision took 1.1 hours (range, 0.4-4.4 hours), compared to 0.7 hours (range 0.1-2.0 hours) for the RO-revisions to DL contours. Total time reduced by 76% (95%-Confidence Interval: 65%-88%) and RO-revision time reduced by 35% (95%-CI,-39%-91%). All geometric and dosimetric metrics computed, agreement with GS was equivalent or significantly greater (p<0.05) for RO-revised DL contours compared to the RO-revised MDA contours, including volumetric Dice similarity coefficient (VDSC), surface DSC, added path length, and the 95%-Hausdorff distance. 32 OARs (76%) had mean VDSC greater than 0.8 for the RO-revised DL contours, compared to 20 (48%) for RO-revised MDA contours, and 34 (81%) for the unrevised DL OARs. Conclusion: DL autosegmentation demonstrated significant time-savings for organ-at-risk contouring while improving agreement with the institutional GS, indicating comparable accuracy of DL model. Integration into the clinical practice with a prospective evaluation is currently underway.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: United States Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: United States Country of publication: Switzerland